|
Analytical validation of an immune response assay for classifying solid tumors. |
|
|
|
Stock and Other Ownership Interests - OmniSeq |
Research Funding - OmniSeq |
Patents, Royalties, Other Intellectual Property - OmniSeq |
|
|
|
Research Funding - OmniSeq |
|
|
|
Research Funding - OmniSeq |
|
Antonios Papanicolau-Sengos |
No Relationships to Disclose |
|
|
|
|
|
|
Research Funding - OmniSeq |
|
|
Research Funding - ITeos Therapeutics (Inst) |
|
|
Stock and Other Ownership Interests - Bristol-Myers Squibb; CVS CAREMARK; GE Healthcare; Nestle health science; Pfizer |
Consulting or Advisory Role - ALKERMES; Bristol-Myers Squibb; Merck |
Research Funding - Alkermes; Altor BioScience; Bristol-Myers Squibb; Merck; Polynoma |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Myriad Genetics |
|
|
No Relationships to Disclose |
|
|
Employment - BioReference Laboratories; OmniSeq |
|
|
Employment - OmniSeq; Thermo Fisher Scientific |
|
Stock and Other Ownership Interests - OmniSeq |
|
|
|
|
Stock and Other Ownership Interests - OmniSeq |
Research Funding - OmniSeq |
Patents, Royalties, Other Intellectual Property - OmniSeq |